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Abstract. In recent years, the number of papers on Alzheimer’s disease
classification has increased dramatically, generating interesting method-
ological ideas on the use machine learning and feature extraction meth-
ods. However, practical impact is much more limited and, eventually, one
could not tell which of these approaches are the most efficient. While
over 90% of these works make use of ADNI an objective comparison
between approaches is impossible due to variations in the subjects in-
cluded, image pre-processing, performance metrics and cross-validation
procedures. In this paper, we propose a framework for reproducible clas-
sification experiments using multimodal MRI and PET data from ADNI.
The core components are: 1) code to automatically convert the full ADNI
database into BIDS format; 2) a modular architecture based on Nipype
in order to easily plug-in different classification and feature extraction
tools; 3) feature extraction pipelines for MRI and PET data; 4) base-
line classification approaches for unimodal and multimodal features. This
provides a flexible framework for benchmarking different feature extrac-
tion and classification tools in a reproducible manner. Data management
tools for obtaining the lists of subjects in AD, MCI converter, MCI non-
converters, CN classes are also provided. We demonstrate its use on all
(1519) baseline T1 MR images and all (1102) baseline FDG PET images
from ADNI 1, GO and 2 with SPM-based feature extraction pipelines
and three different classification techniques (linear SVM, anatomically
regularized SVM and multiple kernel learning SVM). The highest accu-
racies achieved were: 91% for AD vs CN, 83% for MCIc vs CN, 75% for
MCIc vs MCInc, 94% for AD-Aβ+ vs CN-Aβ- and 72% for MCIc-Aβ+
vs MCInc-Aβ+. The code is publicly available1 .
1 Code at https://gitlab.icm-institute.org/aramislab/AD-ML - Depends on the
Clinica software platform, publicly available at http://www.clinica.run
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1 Introduction
Alzheimer’s disease (AD) accounts for over 20 million cases worldwide. Biologi-
cal and brain imaging markers of AD contain information about complementary
processes of the disease progression: in anatomical MRI the atrophy due to gray
matter loss, hypometabolism in fluorodeoxyglucose (FDG) PET, the accumu-
lation of amyloid-beta protein in the brain tissue in amyloid PET imaging, as
well as concentrations of tau and amyloid-beta proteins in cerebrospinal fluid
through lumbar puncture. A major interest is then to analyze those markers to
identify AD at an early stage.
To this end, a large number of machine learning approaches have been proposed
(see [16,4,14] for a review). Such approaches differ by: i) brain image processing
pipelines, 2) feature extraction and selection; 3) machine learning algorithms
(classification and/or regression methods). Furthermore, while initial efforts had
made use of a single imaging modality (usually anatomical MRI) [15,19,12,10,18],
a large number of works have proposed to combine multiple modalities (MRI and
PET neuroimaging, fluid biomarkers) [2,7,9,1,17,6]. In particular, the combina-
tion of anatomical MRI and FDG PET is the most common.
Validation and comparison of such approaches require a large number of patients
with multimodal data and followed over time. The vast majority (over 90%) of
published works use the publicly available Alzheimer’s Disease Neuroimaging
Initiative (ADNI). However, objective comparison between their results is impos-
sible because they use: i) different subsets of patients (with unclear specification
of selection criteria); ii) different preprocessing pipelines (and thus it is not clear
if the superior performance comes for the classification or the preprocessing);
iii) different evaluation metrics; iv) different cross-validation procedures. At the
end, it is very difficult to conclude which methods perform the best and even if a
given modality provides useful additional information. As a result, the practical
impact of these works has remained very limited.
Comparison papers [12,11] and challenges [3,5] have been an important step to-
wards objective evaluation of machine learning methods, by allowing to bench-
mark different approaches on the same dataset and with the same preprocessing.
Nevertheless, such studies provide a ”static” assessment of approaches. Evalua-
tion datasets are used in their current state at the time of the study, whereas
new patients are continuously included in studies such as ADNI. Similarly, they
are limited to the classification and preprocessing methods that were used at the
time of the study. It is thus difficult to complement them with new approaches.
In this paper, we propose a framework for reproducible evaluation of machine
learning algorithms in AD and demonstrate its use on multimodal classification
of PET and MRI data of the ADNI database. Specifically, our contributions are
three-fold: i) a framework for management of ADNI data and their continuous
update with new subjects; ii) a modular set of preprocessing pipelines, feature
extraction and classification methods, that provide a baseline for benchmarking
of different components; iii) a large-scale evaluation of the added value of the
combination of anatomical MRI and FDG PET on 967 patients. By providing
a fully automatic conversion into BIDS format, we offer a huge saving of time
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to users, compared to simply making public the list of used subjects. This is
particularly true for complex multimodal datasets like ADNI (with plenty of
incomplete data, multiple instances of a given modality and complex metadata).
Such a standardized data curation also allows future inclusion of other datasets
in a transparent way, perfect for external validation (e.g. the Australian Imaging
Biomarker and Lifestyle study, AIBL).
Currently, we include relatively standard T1 and (FDG and AV45) PET pipelines
and voxel-based SVM classification. The idea is not to impose their use, but to
provide a set of baseline tools against which new methods can be easily compared.
Researchers working on novel methods can then easily replace a given part of
the pipeline (e.g. feature extraction, classification) with their own approach,
and evaluate the added value of this specific new component over the baseline
approach provided.
2 Material and methods
In order to serve methodological developments and to provide a common frame-
work for evaluation and comparison of methods, we developed a unified set of
tools for data management, image preprocessing, feature extraction and classi-
fication. Data management tools allow to easily update the dataset as new sub-
jects become available in ADNI. Processing and classification tools have been
designed in a modular way using Nipype library to allow the development and
testing of other methods as replacement for a given step. Then, the impact of
each method in the results can be objectively measured. A simple command line
interface is provided and the code can also be used as a Python library.
2.1 Dataset
ADNI, together with follow ups ADNI GO and ADNI2, is a publicly available
database. Overall, it comprises over 300 patients with AD, over 850 patients with
mild cognitive impairment (MCI) and over 350 control subjects. An important
difficulty with ADNI lies in the organization of the public database. Imaging
data, in the state it is downloaded, lacks of a clear structure, and there are
multiple image acquisitions for a given visit of a subject. The complementary
image information is contained in numerous csv files, making the exploration of
the database and subject selection very complicated.
2.2 A standardized data structure
To organize the data, we selected the Brain Imaging Data Structure (BIDS)[8], a
community standard to store multiple neuroimaging modalities. Being based on
a file hierarchy, rather than a database management system, BIDS can be easily
deployed in any environment. For ADNI, among the multiple scans for a visit,
we selected a single scan by imaging modality for each subject. In the case of
T1 scans, gradwarp and B1-inhomogeneity corrected images were selected when
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available, otherwise the original image was selected. When repeated MRI were
available for a single session, the higher quality scan (as identified in ADNI csv
files) was chosen. 1.5T images were preferred for ADNI-1 since they are available
for a larger number of patients. For PET scans, the co-registered averaged across
time frames images were selected.
Very importantly, we provide the code that performs these selections in a fully
automated way. The code receives as input a folder containing the download of
all ADNI data (in their raw format) and creates a BIDS organized version (T1
MRI, FDG and AV-45 PET). This allows direct reproducibility by other groups
without having to redistribute ADNI data, which is not allowed. We also provide
tools for subject selection according to desired imaging modalities, time of follow
up and diagnose, which make possible to use the same groups with the largest
possible number of subjects across studies. Finally, we propose a BIDS-inspired
standardized structure for all outputs of the experiments.
2.3 Preprocessing and feature extraction pipelines
Two pipelines for processing anatomical T1 MRI and PET images were devel-
oped. Pipelines have a modular structure based on Nipype allowing to easily
connect and/or replace components. For anatomical T1 MRI, SPM12 was used
to perform tissue segmentation (GM, WM, CSF) based on the Unified Segmen-
tation procedure. Next, a DARTEL template is created for all the subjects and
a registration to MNI space (DARTEL to MNI) is carried on each of them. The
result is that all the images are in a common space, providing a voxel-wise cor-
respondence across subjects. For PET images, we perform a registration of PET
data onto the corresponding T1 image in native space. An optional partial vol-
ume correction (PVC) step is included using different tissue maps from the T1
in native space. Then the registration into MNI space using the same transfor-
mation as for the corresponding T1 and the generation of a parametric image by
normalization to a reference region (the reference region is eroded pons for FDG
PET, eroded pons and cerebellum combined for amyloid PET) and masking of
non-brain regions are performed.
2.4 Classification methods
The obtained images for all the subjects and for each modality lie in a common
space so they can be analyzed voxel-wise. The currently implemented classi-
fiers use voxel-as-features (i.e. GM maps for T1 MRI and parametric FDG PET
images). Other types of features such as regional features could be easily im-
plemented in the future. We implemented different classifiers for unimodal (T1
MRI or FDG PET) and multimodal classification.
Unimodal classification. Linear SVM. The first method included to classify
single modality images is a linear SVM. For the specified modality, a linear
kernel is calculated using the inner product for each pair of images (using all
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the voxels) for the provided subjects. This kernel is used as input for the generic
SVM (makes use of scikit-learn library2). Given its simplicity it is useful as a
baseline to compare the performance of methods.
Spatially and anatomically regularized SVM. The L2 regularization of the stan-
dard SVM does not take into account the spatial and anatomical structure of
brain images. As a result, the solutions are not easily interpretable (the ob-
tained hyperplanes are highly scattered). To overcome this issue, we implement
a classifier that combines a spatial regularization and an atlas based anatomical
regularization by using the Fisher metric as proposed by [13]. The spatial prox-
imity takes into account the distance between voxels while anatomical proximity
is defined as if two voxels belong to the same atlas defined region or tissue (in our
case GM, WM and CSF probability maps). This approach was initially proposed
by [13] in the case of T1 MRI. Here, we extend it to FDG PET images. The
implementation of this approach provides a baseline classifier with interpretable
maps that can be used for comparison of other methods.
Multimodal classification. For multimodal classification, we included a sim-
ple implementation of Multiple Kernel Learning (MKL) for the case of two
modalities. A kernel is obtained from the linear combination of two kernels ob-
tained for each imaging modality separately, and then provided as input to the
SVM: KT1-FDG = αKT1 + (1− α)KFDG, 0 ≤ α ≤ 1
Parameter α that maximizes the balanced accuracy is determined by cross vali-
dation. This parameter weights the initial kernels into the combined kernel and
therefore represents the contribution of each imaging modality into the classifi-
cation result.
2.5 Validation
Cross-validation. To assess classification performance without bias, it is im-
portant to carefully perform cross-validation (CV). In particular, CV must not
only concern the training of the classifier, but also the optimization of hyper-
parameters. While the former is usually dealt with correctly, the latter has not
always been appropriately performed in the literature. Here, we implemented
two nested CV procedures for hyperparameter optimization and classifier train-
ing. By default, a 10-fold CV is implemented in our framework, and an input
parameter lets the user select the number of desired folds.
Metrics. As output of the classification, we report AUC, accuracy, balanced ac-
curacy, sensitivity, specificity and in addition the predicted class for each subject
so that the user could calculate any other metric with this information. Also, an
image with the SVM weights for each feature is provided. Such weights live in
the same space as the MRI and PET images and can thus be used to visualize
the brain regions that contributed to the classification.
2 http://scikit-learn.org
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3 Results
We applied the preprocessing pipelines to all (1519) baseline T1 MR images and
all (1102) baseline FDG PET images from ADNI 1, GO and 2. Subjects were
grouped as AD(239), MCI converter(164), MCI non converter(309) or CN(255),
according to diagnosis determined for 36 months of follow up (967 subjects in
total). Another grouping was done also taking into account amyloid imaging
as AD-Aβ+(125), MCIc-Aβ+(81), MCIc-Aβ-(5), MCInc-Aβ+(105), MCInc-Aβ-
(131) and CN-Aβ-(111).
Classification for AD vs CN, MCIc vs CN and MCIc vs MCInc, AD-Aβ+ vs CN-
Aβ- and MCIc-Aβ+ vs MCInc-Aβ+ classification tasks was performed using
voxel-based linear SVM and spatially and anatomically regularized SVM for
each modality separately (T1 and FDG PET). Also the multiple-kernel SVM
was used on the combination of linear and regularized kernels for T1 and FDG
PET obtained in the previous step. Classification results were averaged over 10
runs. Results can be observed in Table 1.
Overall, the use of FDG PET provided better results than T1 in general (bal-
anced accuracy of 91% for AD vs CN, 83% for MCIc vs CN, 75% for MCIc vs
MCInc, 94% for AD-Aβ+ vs CN-Aβ- and 72% for MCIc-Aβ+ vs MCInc-Aβ+),
but it significantly outperforms it in the case of conversion prediction (MCIc vs
MCInc and MCIc-Aβ+ vs MCInc-Aβ+ tasks).
The combination of different modality kernels confirms this result, providing as
best linear combination the case when only FDG PET data was selected, giving
no weight to GM kernel.
The use of amyloid imaging to refine groups improved the classification results
only for FDG PET in the case of AD-Aβ+ vs CN-Aβ- and not in every task as
expected.
4 Conclusions
We proposed a framework for reproducible machine learning experiments on au-
tomatic classification using the ADNI database. It features a standardized data
management and a modular architecture for preprocessing, feature extraction
and classification. Of note, the dataset can be continuously updated as more
data become available. We provide processing pipelines for T1 MRI and PET
images as well as classification tools for unimodal and multimodal data.
We applied this framework to classify T1 MRI and FDG PET data. We demon-
strate that FDG PET imaging provides superior accuracy over T1 MRI when
predicting Alzheimer’s disease conversion in MCI patients. Furthermore, com-
bination of both modalities did not result in superior accuracy over FDG PET
alone. However, more sophisticated combinations may lead to improvements.
The use of amyloid imaging to refine groups of subjects didn’t improve results
in general, but it might be due to the significantly lower subject counts. The
classification accuracy for AD vs CN and MCIc vs CN are in line with the state
of the art. Nevertheless, there are some papers that report higher accuracy for
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Fig. 1. Normalized wopt coefficients ≥ 0 for AD vs CN: (a) T1 linear SVM,
(b) T1 regularized SVM, (c) FDG PET linear SVM, (d) FDG PET regularized SVM
prediction of conversion. Our lower accuracy might be due to the fact that we
used all available patients, avoiding cherry-picking effects.
The code associated to this work will be made available at the time of the
conference. We believe that it will be a useful tool for the community to progress
towards more reproducible results in this field.
Image type Classifier Task AUC
Bal
Sens Spec
acc
T1 Linear SVM
AD vs CN 94.2% 88.8% 92.8% 84.8%
MCIc vs CN 85.5% 80.5% 66.8% 89.3%
MCIc vs MCInc 73.8% 66.5% 64.9% 69.3%
AD-Aβ+ vs CN-Aβ- 93.6% 87.9% 90.5% 85.5%
MCIc-Aβ+ vs MCInc-Aβ+ 73.6% 65.8% 69.8% 60.3%
FDG PET Linear SVM
AD vs CN 96.7% 91.1% 95% 87.2%
MCIc vs CN 89.1% 83.5% 74.7% 89.2%
MCIc vs MCInc 80.5% 75.2% 78.5% 69.4%
AD-Aβ+ vs CN-Aβ- 98.6% 94.4% 95.6% 93.4%
MCIc-Aβ+ vs MCInc-Aβ+ 80.8% 72.8% 77% 67%
Table 1. Classification results (mean of 10 runs)
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Supplementary material
Image type Classifier Task AUC
Bal
Sens Spec
acc
T1
Linear SVM
AD vs CN 94.2% 88.8% 92.8% 84.8%
MCIc vs CN 85.5% 80.5% 66.8% 89.3%
MCIc vs MCInc 73.8% 66.5% 64.9% 69.3%
AD-Aβ+ vs CN-Aβ- 93.6% 87.9% 90.5% 85.5%
MCIc-Aβ+ vs MCInc-Aβ+ 73.6% 65.8% 69.8% 60.3%
Regul SVM
AD vs CN 94.9% 90% 92.5% 87.3%
MCIc vs CN 86.5% 81.2% 74.7% 85.4%
MCIc vs MCInc 74.8% 67.3% 66.8% 68.8%
AD-Aβ+ vs CN-Aβ- 94.9% 88.1% 92.5% 84.2%
MCIc-Aβ+ vs MCInc-Aβ+ 73.5% 65.4% 56.8% 76.2%
FDG PET
Linear SVM
AD vs CN 96.7% 91.1% 95% 87.2%
MCIc vs CN 89.1% 83.5% 74.7% 89.2%
MCIc vs MCInc 80.5% 75.2% 78.5% 69.4%
AD-Aβ+ vs CN-Aβ- 98.6% 94.4% 95.6% 93.4%
MCIc-Aβ+ vs MCInc-Aβ+ 80.8% 72.8% 77% 67%
Regul SVM
AD vs CN 96.7% 91.1% 94.8% 86.9%
MCIc vs CN 88.8% 83.0% 76.5% 87.1%
MCIc vs MCInc 80.4% 73.7% 74.5% 71.9%
AD-Aβ+ vs CN-Aβ- 98.7% 95.4% 96.9% 93.8%
MCIc-Aβ+ vs MCInc-Aβ+ 78.0% 71.3% 73.5% 67.8%
Table 2. Classification results for T1 and FDG PET modalities (mean of 10 runs)
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Image type Classifier Task
Bal
Sens Spec
acc
T1+FDG PET
Linear SVM
AD vs CN 90% 93% 87%
MCIc vs CN 81% 88% 73%
MCIc vs MCInc 73% 79% 68%
AD-Aβ+ vs CN-Aβ- 95% 95% 94%
MCIc-Aβ+ vs MCInc-Aβ+ 73% 77% 69%
Regul SVM
AD vs CN 92% 95% 89%
MCIc vs CN 82% 87% 77%
MCIc vs MCInc 72% 75% 69%
AD-Aβ+ vs CN-Aβ- 96% 97% 95%
MCIc-Aβ+ vs MCInc-Aβ+ 72% 77% 67%
Table 3. Best classification results for MKL combining T1 and FDG PET
